PubMed

Contribution of protein binding to the pharmacokinetics of the ghrelin receptor agonist TZP-101 in healthy volunteers and adults with symptomatic gastroparesis: two randomized, double-blind studies and a binding profile study.

Wargin W, Thomas H, Clohs L, St-Louis C, Ejskjaer N, Gutierrez M, Shaughnessy L, Kosutic G.

Clin Drug Investig. 2009;29(6):409-18. doi: 10.2165/00044011-200929060-00004.PMID: 19432500 [PubMed - indexed for MEDLINE]Related articles

Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.

Ejskjaer N, Vestergaard ET, Hellström PM, Gormsen LC, Madsbad S, Madsen JL, Jensen TA, Pezzullo JC, Christiansen JS, Shaughnessy L, Kosutic G.

Aliment Pharmacol Ther. 2009 Jun 1;29(11):1179-87. Epub 2009 Feb 27.PMID: 19298585 [PubMed - in process]Related articles

Ghrelin agonist (TZP-101): safety, pharmacokinetics and pharmacodynamic evaluation in healthy volunteers: a phase I, first-in-human study.

Lasseter KC, Shaughnessy L, Cummings D, Pezzullo JC, Wargin W, Gagnon R, Oliva J, Kosutic G.

J Clin Pharmacol. 2008 Feb;48(2):193-202.PMID: 18199894 [PubMed - indexed for MEDLINE]Related articles

Pharmacokinetics of modified oral calcitonin product in healthy volunteers.

Chin CM, Gutierrez M, Still JG, Kosutic G.

Pharmacotherapy. 2004 Aug;24(8):994-1001.PMID: 15338848 [PubMed - indexed for MEDLINE]Related articles

Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial.

Clement S, Dandona P, Still JG, Kosutic G.

Metabolism. 2004 Jan;53(1):54-8.PMID: 14681842 [PubMed - indexed for MEDLINE]Related articles

Oral heparin administration with a novel drug delivery agent (SNAC) in healthy volunteers and patients undergoing elective total hip arthroplasty.

Berkowitz SD, Marder VJ, Kosutic G, Baughman RA.

J Thromb Haemost. 2003 Sep;1(9):1914-9.PMID: 12941031 [PubMed - indexed for MEDLINE]Related articles

Control of postprandial plasma glucose by an oral insulin product (HIM2) in patients with type 2 diabetes.

Kipnes M, Dandona P, Tripathy D, Still JG, Kosutic G.

Diabetes Care. 2003 Feb;26(2):421-6.PMID: 12547873 [PubMed - indexed for MEDLINE]Related articlesFree article

Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2.

Clement S, Still JG, Kosutic G, McAllister RG.

Diabetes Technol Ther. 2002;4(4):459-66.PMID: 12396740 [PubMed - indexed for MEDLINE]Related articles